164 related articles for article (PubMed ID: 11758957)
1. Revising the decision analysis for febrile children at risk for occult bacteremia in a future era of widespread pneumococcal immunization.
Yamamoto LG
Clin Pediatr (Phila); 2001 Nov; 40(11):583-94. PubMed ID: 11758957
[TBL] [Abstract][Full Text] [Related]
2. A revised decision analysis of strategies in the management of febrile children at risk for occult bacteremia.
Yamamoto LG; Worthley RG; Melish ME; Seto DS
Am J Emerg Med; 1998 Mar; 16(2):193-207. PubMed ID: 9517704
[TBL] [Abstract][Full Text] [Related]
3. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis.
Lee GM; Fleisher GR; Harper MB
Pediatrics; 2001 Oct; 108(4):835-44. PubMed ID: 11581433
[TBL] [Abstract][Full Text] [Related]
4. Occult pneumococcal bacteremia: a review.
Joffe MD; Alpern ER
Pediatr Emerg Care; 2010 Jun; 26(6):448-54; quiz 455-7. PubMed ID: 20531134
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine.
Carstairs KL; Tanen DA; Johnson AS; Kailes SB; Riffenburgh RH
Ann Emerg Med; 2007 Jun; 49(6):772-7. PubMed ID: 17337092
[TBL] [Abstract][Full Text] [Related]
6. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center.
Stoll ML; Rubin LG
Arch Pediatr Adolesc Med; 2004 Jul; 158(7):671-5. PubMed ID: 15237067
[TBL] [Abstract][Full Text] [Related]
7. The role of parental preferences in the management of fever without source among 3- to 36-month-old children: a decision analysis.
Madsen KA; Bennett JE; Downs SM
Pediatrics; 2006 Apr; 117(4):1067-76. PubMed ID: 16585300
[TBL] [Abstract][Full Text] [Related]
8. Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization.
Klein JO
Pediatr Infect Dis J; 2002 Jun; 21(6):584-8; discussion 613-4. PubMed ID: 12182394
[TBL] [Abstract][Full Text] [Related]
9. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department.
Sard B; Bailey MC; Vinci R
Pediatr Emerg Care; 2006 May; 22(5):295-300. PubMed ID: 16714955
[TBL] [Abstract][Full Text] [Related]
10. Predictors of occult bacteremia in young febrile children in the era of heptavalent pneumococcal conjugated vaccine.
Mintegi S; Benito J; Sanchez J; Azkunaga B; Iturralde I; Garcia S
Eur J Emerg Med; 2009 Aug; 16(4):199-205. PubMed ID: 19593900
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.
Sisk JE; Moskowitz AJ; Whang W; Lin JD; Fedson DS; McBean AM; Plouffe JF; Cetron MS; Butler JC
JAMA; 1997 Oct 22-29; 278(16):1333-9. PubMed ID: 9343464
[TBL] [Abstract][Full Text] [Related]
12. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
[TBL] [Abstract][Full Text] [Related]
13. Occult bacteremia in the post-pneumococcal conjugate vaccine era: does the blood culture stop here?
Avner JR; Baker MD
Acad Emerg Med; 2009 Mar; 16(3):258-60. PubMed ID: 19183109
[No Abstract] [Full Text] [Related]
14. Febrile seizures with leukocytosis as a predictor for occult bacteremia.
Ogawa E; Shoji K; Kamidani S; Miyairi I
Pediatr Int; 2019 Jun; 61(6):578-582. PubMed ID: 30980459
[TBL] [Abstract][Full Text] [Related]
15. Reevaluation of outpatients with Streptococcus pneumoniae bacteremia.
Bachur R; Harper MB
Pediatrics; 2000 Mar; 105(3 Pt 1):502-9. PubMed ID: 10699100
[TBL] [Abstract][Full Text] [Related]
16. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.
Farr BM; Johnston BL; Cobb DK; Fisch MJ; Germanson TP; Adal KA; Anglim AM
Arch Intern Med; 1995 Nov; 155(21):2336-40. PubMed ID: 7487259
[TBL] [Abstract][Full Text] [Related]
17. Bacteremia in febrile children under 3 years of age in an emergency department of a university hospital.
Al-Rashed AM
Saudi Med J; 2008 Feb; 29(2):229-33. PubMed ID: 18246232
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and management of the febrile child in the conjugated vaccine era.
Akintemi OB; Roberts KB
Adv Pediatr; 2006; 53():255-78. PubMed ID: 17089871
[No Abstract] [Full Text] [Related]
19. [Economic evaluation of an infant immunization program in Mexico, based on 13-valent pneumococcal conjugated vaccines].
Muciño-Ortega E; Mould-Quevedo JF; Farkouh R; Strutton D
Value Health; 2011; 14(5 Suppl 1):S65-70. PubMed ID: 21839902
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
